INCR — Intercure Ltd.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1857030 ·
Last close
$5.03
Market Cap
$75.47M
52W High
$8.45
52W Low
$3.40
ADV30
6,625
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Dec 2025 | — | — | — | — | 690,552,000 | 46,466,000 | 294,195,000 |
| Dec 2024 | — | — | — | — | 762,574,000 | 78,318,000 | 364,903,000 |
Balance + Analyst (yfinance extras)
Retained Earnings
$-314,615,000
Inventory
$108,064,000
Receivables
$154,470,000
ST Investments
$209,000
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 270,200,000 | 6,733,000 | -35,710,000 | 690,552,000 | 294,195,000 | 396,521,000 | 16,841,000 |
| Dec 2024 | 238,845,000 | -45,056,000 | -67,795,000 | 762,574,000 | 364,903,000 | 396,969,000 | -66,926,000 |
| Dec 2023 | 355,553,000 | 37,593,000 | -61,959,000 | 786,614,000 | 329,552,000 | 455,112,000 | -53,631,000 |
| Dec 2022 | 388,684,000 | 41,200,000 | 44,819,000 | 958,007,000 | 436,530,000 | 501,305,000 | 51,267,000 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-1.48
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| RFL | Rafael Holdings, Inc. | $75.79M | $1.48 | — |
| MNOV | MEDICINOVA INC | $75.80M | $1.54 | — |
| OSTX | OS Therapies Inc | $75.82M | $1.62 | — |
| LFVN | Lifevantage Corp | $75.04M | $5.99 | — |
| NTHI | NEONC TECHNOLOGIES HOLDINGS, INC. | $72.88M | $2.53 | — |
News headlines (Yahoo Finance, 1h cache)
InterCure Regains Compliance with Nasdaq Minimum Bid Price Requirement
2026-09-08 20:12 · Yahoo
InterCure (INCR) Finalized a $77M Settlement, but How Much New Cash Will it Receive?
2026-08-27 20:22 · Yahoo
InterCure Ltd. Announces 1-for-5 Reverse Share Split
2026-08-19 13:00 · Yahoo
InterCure Finalizes NIS 230 Million (~US$77 Million) Settlement for War-Related Indirect Damages
2026-08-24 11:00 · Yahoo
InterCure Secures NIS 22 Million in Private Placement Financing Led by Leading Pharma-Focused Hedge Funds
2026-06-22 12:50 · Yahoo
InterCure Initiates Strategic Review of U.S. Medical Cannabis Opportunities Following Historic Federal Rescheduling and Completes the Initial closing of Botanico Acquisition
2026-06-15 13:25 · Yahoo
InterCure Announces 2025 Results with NIS 270 Million in Revenue and Positive Operating Cash Flow
2026-04-30 22:05 · Yahoo
InterCure Announces Preliminary Estimated 2025 Revenue of NIS 265 Million, Positive Adjusted EBITDA and Cash of NIS 43 Million
2026-02-19 12:00 · Yahoo
InterCure Announces Preliminary Estimated 2025 Revenue of NIS 265 Million, Positive Adjusted EBITDA and Cash¹ of NIS 43 Million
2026-02-19 12:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.